Compare Cassava Sciences Inc (FLNA) vs Noble Corporation plc (NE) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Noble Corporation (NE) trades at $40.49, down 2.86% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.26, beating expectations, and secured new drilling contracts in Brunei and the UK. Financials show stable revenue around $3.3 billion and improving net margins, with a P/E of 28.38 and EV/EBITDA of 7.3 indicating moderate valuation.

Outlook is cautiously positive with a consensus price target of $49.75, though recent earnings misses and competitive pressures pose risks. The stock offers potential upside from contract wins and operational efficiency, but investors should weigh volatility in energy services demand and execution risks against the 31% analyst buy rating.